gip/glp 1-agonist tirzepatide Frontiers Tirzepatide's Unique Mechanism of Action
Description
The Name Behind This Natural GLP-1
is a recipient of ABOARD, which is a publicprivate partnership receiving funding from ZonMw (#73305095007) and Health~Holland (Topsector Life Sciences & Health) (publicprivate partnership allowance
Bottom line GLP-1 drugs can be effective tools for weight loss and blood sugar control
It is injected once weekly at doses ranging from 0.25 mg (starting dose) to 2.0 mg (maximum dose for diabetes)
This is why the larger phase 3 and cardiovascular outcomes trials are essential
